Nivolumab With Gemcitabine, Oxaliplatin + Rituximab in r/r Elderly Lymphoma Patients

NCT03366272 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

348

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, Non-Hodgkin

Interventions

DRUG: Nivolumab
DRUG: Rituximab
DRUG: Gemcitabine
DEVICE: Oxaliplatin

Sponsor

Universität des Saarlandes

Collaborators

[object Object]
[object Object]
[object Object]